1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Eye Infections Global Clinical Trials Review, H2, 2015

Eye Infections Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Eye Infections Global Clinical Trials Review, H2, 2015" provides an overview of Eye Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Eye Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Eye Infections Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Eye Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Eye Infections to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Eye Infections to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Eye Infections 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Eye Infections Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Merck and Co., Inc. 32
Clinical Trial Overview of Merck and Co., Inc. 32
Valeant Pharmaceuticals International, Inc. 33
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 33
Laboratoires Thea S.A. 34
Clinical Trial Overview of Laboratoires Thea S.A. 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
InSite Vision Incorporated 36
Clinical Trial Overview of InSite Vision Incorporated 36
Alcon, Inc. 37
Clinical Trial Overview of Alcon, Inc. 37
Ajanta Pharma Limited 38
Clinical Trial Overview of Ajanta Pharma Limited 38
SIFI S.p.A 39
Clinical Trial Overview of SIFI S.p.A 39
Dompe Farmaceutici S.p.A. 40
Clinical Trial Overview of Dompe Farmaceutici S.p.A. 40
Allergan Plc 41
Clinical Trial Overview of Allergan Plc 41
Clinical Trial Overview of Top Institutes / Government 42
Federal University of Sao Paulo 42
Clinical Trial Overview of Federal University of Sao Paulo 42
National Eye Institute 43
Clinical Trial Overview of National Eye Institute 43
University of California, Los Angeles 44
Clinical Trial Overview of University of California, Los Angeles 44
Chulalongkorn University 45
Clinical Trial Overview of Chulalongkorn University 45
Massachusetts Eye and Ear Infirmary 46
Clinical Trial Overview of Massachusetts Eye and Ear Infirmary 46
University of California, San Francisco 47
Clinical Trial Overview of University of California, San Francisco 47
University of Sao Paulo 48
Clinical Trial Overview of University of Sao Paulo 48
University of Tsukuba 49
Clinical Trial Overview of University of Tsukuba 49
All India Institute of Medical Sciences 50
Clinical Trial Overview of All India Institute of Medical Sciences 50
Ann and Robert H. Lurie Children's Hospital of Chicago 51
Clinical Trial Overview of Ann and Robert H. Lurie Children's Hospital of Chicago 51
Five Key Clinical Profiles 52
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 77

List of Tables
Eye Infections Therapeutics, Global, Clinical Trials by Region, 2015* 7
Eye Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Eye Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Eye Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Eye Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Eye Infections Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Eye Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Eye Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Eye Infections to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Eye Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Eye Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Eye Infections to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Eye Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Eye Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Eye Infections Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Eye Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Eye Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Eye Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Eye Infections Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Eye Infections Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Eye Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Eye Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Eye Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Eye Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Eye Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 32
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 33
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Thea S.A., 2015* 34
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 35
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by InSite Vision Incorporated, 2015* 36
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon, Inc., 2015* 37
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Ajanta Pharma Limited, 2015* 38
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by SIFI S.p.A, 2015* 39
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Dompe Farmaceutici S.p.A., 2015* 40
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015* 41
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 42
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 43
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2015* 44
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Chulalongkorn University, 2015* 45
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts Eye and Ear Infirmary, 2015* 46
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 47
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2015* 48
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tsukuba, 2015* 49
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015* 50
Eye Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Ann and Robert H. Lurie Children's Hospital of Chicago, 2015* 51

List of Figures
Eye Infections Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Eye Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Eye Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Eye Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Eye Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Eye Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Eye Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Eye Infections Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Eye Infections to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Eye Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Eye Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Eye Infections to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Eye Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Eye Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Eye Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Eye Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Eye Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Eye Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Eye Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Eye Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Eye Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Eye Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Eye Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 75

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.